Source comparison
Thymosin Alpha-1 Animal Research: Study Design Comparison
Thymectomized mice CD4+/CD8+ ratio restoration 0.05–0.2 mg/kg Thymic-dependent T-cell maturation High for primary immunodeficiency Viral hepatitis (woodchuck) Viral DNA reduction, ALT normalization 1.0–2.0 mg/kg Th1 cytokine upregulation, enhanced viral cleara
This comparison does not assign a generated winner or score.
- Thymectomized mice
- CD4+/CD8+ ratio restoration
- 0.05–0.2 mg/kg
- Thymic-dependent T-cell maturation
- High for primary immunodeficiency
- Viral hepatitis (woodchuck)
- Viral DNA reduction, ALT normalization
- 1.0–2.0 mg/kg
- Th1 cytokine upregulation, enhanced viral clearance
- Direct for chronic hepatitis B
- Murine sepsis (CLP model)
- 7-day survival, organ failure scores
- 1.6–3.2 mg/kg
- IL-10 suppression, prevention of CARS phase
- Moderate for septic shock
- Influenza infection (mice)
- Survival rate, lung viral titers
- 0.8–1.6 mg/kg
- Pre-emptive T-cell priming, IFN-gamma production
- Moderate for pandemic preparedness
- Aging/senescence models
- Thymic output, naive T-cell frequency
- 0.4–1.0 mg/kg
- Reversal of age-related thymic involution
- Emerging for immunosenescence